Ulcerative colitis is an autoimmune condition caused by the body’s immune system attacking itself. This causes continuous segments of inflammation in the gut wall, affecting the colon and rectum only. 2 in 1,000 adults in the UK are affected by ulcerative colitis.
Ulcerative Colitis Treatment
Treatment for ulcerative colitis is separated into two components. The first aim is to treat active symptoms (flare-up) and then once a flare-up is settled to maintain remission.
Treatment for ulcerative colitis is managed in specialist settings. Flare-ups are treated with a short course of immunosuppressant with an aminosalicylate (e.g. mesalazine, sulfasalazine) and/or corticosteroids.
Remission is maintained using a stepwise approach starting with an aminosalicylate and adding in second line therapies (e.g. azathioprine, 6-mercaptopurine) as required. Some patients may require treatment with special medications made from antibodies or surgery.
Medicinal cannabis can be considered when first and second line therapies have not achieved adequate benefit in active ulcerative colitis or disease that is in remission.
If you are a patient or carer seeking an appointment to discuss treatment with medical cannabis, you can complete this form and we can assist you with this.
Eligible patients can provide us with their healthcare records or we can obtain these through your GP. This is to confirm that a patient’s condition has been fully assessed and all other treatment options have been attempted. We will ensure that the primary care provider receives all treatment communication to maintain the highest level of clinical governance.
We also accept referrals from healthcare professionals.
To refer a patient to us, please click here to fill and securely submit a referral form.